Hims & Hers Health, Inc. (HIMS) Fair Value & Valuation Analysis
Hims & Hers Health, Inc. (HIMS) valuation and fair value analysis based on SEC filings. Over the last 5 years its EPS -3.8% and free cash flow/share -0.5% compounded annually (from SEC filings). See whether HIMS looks undervalued or overvalued using P/E, FCF, OCF and DCF models with 5-year projections — Services-Offices & Clinics of Doctors of Medicine.
Related stocks
PLUG POWER INC (PLUG) · Broadcom Inc. (AVGO) · MICRON TECHNOLOGY INC (MU) · QUALCOMM INC/DE (QCOM) · Salesforce, Inc. (CRM) · Snowflake Inc. (SNOW) · Riot Platforms, Inc. (RIOT) · Apple Inc. (AAPL)